Bicara Therapeutics launches $150M public stock offering
Source: SeekingAlpha
2026-02-24 16:09:42 ET
More on Bicara Therapeutics
- Seeking Alpha’s Quant Rating on Bicara Therapeutics
- Historical earnings data for Bicara Therapeutics
- Financial information for Bicara Therapeutics
Read the full article on Seeking Alpha
For further details see:
Bicara Therapeutics launches $150M public stock offering
Bicara Therapeutics Inc.
NASDAQ: BCAX
BCAX Trading
1.33% G/L:
$18.735 Last:
72,983 Volume:
$18.27 Open:
BCAX Latest News
March 04, 2026 08:30:00 am
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
February 26, 2026 04:01:00 pm
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
February 24, 2026 11:13:06 pm
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
February 24, 2026 04:01:00 pm
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
BCAX Stock Data
$817,548,781
24,302,552
0.5%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
